Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
AGN [NYSE]
Allergan Inc.
IndexS&P 500 P/E41.11 EPS (ttm)4.37 Insider Own0.10% Shs Outstand297.18M Perf Week1.92%
Market Cap53.39B Forward P/E21.82 EPS next Y8.23 Insider Trans5.32% Shs Float296.61M Perf Month7.94%
Income1.32B PEG2.42 EPS next Q1.47 Inst Own93.70% Short Float1.22% Perf Quarter5.35%
Sales6.75B P/S7.91 EPS this Y17.60% Inst Trans2.23% Short Ratio1.87 Perf Half Y43.17%
Book/sh22.80 P/B7.88 EPS next Y41.99% ROA11.90% Target Price200.60 Perf Year98.18%
Cash/sh12.50 P/C14.37 EPS next 5Y17.00% ROE19.50% 52W Range88.23 - 181.94 Perf YTD61.86%
Dividend0.20 P/FCF37.35 EPS past 5Y17.90% ROI15.70% 52W High-1.25% Beta0.73
Dividend %0.11% Quick Ratio3.80 Sales past 5Y7.40% Gross Margin87.80% 52W Low103.64% ATR3.67
Employees11700 Current Ratio4.10 Sales Q/Q16.70% Oper. Margin30.70% RSI (14)67.85 Volatility2.56% 2.06%
OptionableYes Debt/Eq0.32 EPS Q/Q17.10% Profit Margin18.70% Rel Volume1.55 Prev Close178.19
ShortableYes LT Debt/Eq0.31 EarningsOct 20 BMO Payout4.60% Avg Volume1.93M Price179.67
Recom1.80 SMA205.52% SMA508.37% SMA20023.33% Volume3,001,036 Change0.83%
01-Oct-14Upgrade Stifel Hold → Buy $200
22-Jul-14Upgrade UBS Neutral → Buy $180 → $200
28-Apr-14Downgrade Stifel Buy → Hold
22-Apr-14Downgrade Argus Buy → Hold
07-Mar-14Reiterated Barclays Equal Weight $95 → $130
07-Feb-14Reiterated Argus Buy $110 → $130
08-Jan-14Reiterated Argus Buy $110 → $125
07-Jan-14Initiated RBC Capital Mkts Outperform $131
20-Dec-13Reiterated UBS Buy $100 → $116
20-Dec-13Reiterated BMO Capital Markets Outperform $112 → $117
31-Oct-13Reiterated Argus Buy $118 → $110
25-Jun-13Reiterated Canaccord Genuity Hold $111 → $98
24-Jun-13Downgrade Deutsche Bank Buy → Hold
02-May-13Reiterated RBC Capital Mkts Outperform $123 → $119
06-Feb-13Reiterated Stifel Nicolaus Buy $110 → $118
06-Feb-13Reiterated Canaccord Genuity Hold $102 → $111
22-Jan-13Reiterated Canaccord Genuity Hold $101 → $102
19-Sep-12Initiated Canaccord Genuity Hold $101
30-Mar-12Reiterated RBC Capital Mkts Outperform $93 → $106
29-Mar-12Reiterated UBS Buy $100 → $107
01-Oct-14 07:00PM  Cramer's Message To EBAY And ANGI CNBC
07:00PM  [video] Cramer's Message To EBAY And ANGI at CNBC
12:45PM  Proxy Advisory Firm Seeks Shareholder Vote at Allergan, Maker of Botox at New York Times
12:02PM  Allergan pressed to have shareholder vote on Salix bid at Financial Times
11:09AM  [$$] ISS Urges Shareholder Vote at Allergan at The Wall Street Journal
10:59AM  [$$] ISS Urges Shareholder Vote at Allergan at The Wall Street Journal
10:41AM  Why Allergan (AGN) Stock Is Falling Today at TheStreet
09:35AM  ISS to Allergan: Let shareholders be heard CNBC
09:35AM  [video] ISS to Allergan: Let shareholders be heard at CNBC
07:47AM  Allergan upgraded by Stifel Briefing.com
06:35AM  Ackman's Pershing Square raises $3 bln in fund listing Reuters
05:04AM  Ackman Fund Raises More Than $3 Billion in Amsterdam I.P.O. at New York Times
30-Sep-14 12:09PM  Valeant has a Wrinkle: FDA Letter Cites Problems With a Facial Filler at The Wall Street Journal
11:38AM  Valeant has a Wrinkle: FDA Letter Cites Problems With a Facial Filler at The Wall Street Journal
29-Sep-14 09:25PM  Valeant Pharmaceuticals' third-quarter sales to rise -filing Reuters
07:53PM  Valeant Pharmaceuticals sees third-quarter sales boost Reuters
05:26PM  ALLERGAN INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
05:21PM  Today's Market Thorns, Roses, and All Time Highs... Yahoo Finance Blogs
01:32PM  Rebound Efforts Fade For Stocks; Synchronoss Clears Resistance at Investor's Business Daily
12:34PM  Where the Allergan-Valeant(-Salix-Actavis-Teva) Fights Stand Now at The Wall Street Journal
12:30PM  Dealpolitik: Shareholders May Have Little Influence on Allergan Decision at The Wall Street Journal
09:25AM  ALLERGAN INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
09:00AM  Allergan Announces FDA Approves Revised Indication for OZURDEX┬« (dexamethasone intravitreal implant) 0.7 mg for the Treatment of Diabetic Macular Edema Business Wire
08:52AM  [$$] Allergan Reiterates Opposition to Valeant Bid at The Wall Street Journal
08:00AM  Allergan Board of Directors Issues Statement Business Wire
28-Sep-14 11:23AM  Drugs groups trapped in tangled M&A web at Financial Times
11:05AM  Jackson Square Partners Joins Investors Opposing Allergan Bid for Salix Benzinga
27-Sep-14 09:11PM  Jackson Square Joins Allergan Investors Against Salix Bid at Bloomberg
04:26PM  Major Allergan Investor Joins Chorus Against Salix Deal at New York Times
12:02PM  Shareholder T. Rowe Pirce urges Allergan to hold off on deals Reuters
12:09AM  [$$] T. Rowe Price Urges Allergan to Put Acquisitions to Shareholder Vote at The Wall Street Journal
26-Sep-14 11:24PM  [$$] T. Rowe Price Urges Allergan to Put Acquisitions to Shareholder Vote at The Wall Street Journal
10:57PM  [$$] T. Rowe Price Urges Allergan to Put Acquisitions to Shareholder Vote at The Wall Street Journal
10:17PM  [$$] T. Rowe Price Urges Allergan to Put Acquisitions to Shareholder Vote at The Wall Street Journal
09:19PM  [$$] T. Rowe Price Urges Allergan to Put Acquisitions to Shareholder Vote at The Wall Street Journal
08:31PM  [$$] T. Rowe Price Urges Allergan to Put Acquisitions to Shareholder Vote at The Wall Street Journal
06:23PM  [$$] T. Rowe Price Urges Allergan to Put Acquisitions to a Vote at The Wall Street Journal
05:52PM  [$$] T. Rowe Price Urges Allergan to Put Acquisitions to a Vote at The Wall Street Journal
04:52PM  Why Allergan (AGN) Stock Is Declining in After-Hours Trading Today at TheStreet
04:29PM  [$$] T. Rowe Price Urges Allergan to Put Acquisitions to a Vote at The Wall Street Journal
04:16PM  T. Rowe joins concerns over Allergan governance at CNBC
04:13PM  Shareholder T. Rowe Price urges Allergan to hold off on deals Reuters
04:04PM  Allergan Shareholder T. Rowe Price Criticizes Board at Bloomberg
04:00PM  [$$] T. Rowe Price Urges Allergan to Put Acquisitions to a Vote at The Wall Street Journal
04:00PM  Allergan Writes Back, Coaxes Shareholders Against Valeant Zacks
03:46PM  [$$] T. Rowe Price Urges Allergan to Put Acquisitions to a Vote at The Wall Street Journal
03:38PM  T. Rowe Price urges Allergan to drop Salix bid at MarketWatch
02:40PM  T.Rowe Calls For Shareholder Vote On Allergan's Plans Too at Barrons.com
01:22PM  Shareholder prods Allergan to drop defenses and consider Valeant bid at MarketWatch
12:56PM  Allergan faces downside position optionMONSTER
11:56AM  Two Critical Voices Speak Out on Allergan, Maker of Botox at New York Times
11:56AM  Another Critical Voice Joins Ackman on Allergan at New York Times
11:56AM  Another Critical Voice Joins Ackman on Allergan, Maker of Botox at New York Times
11:50AM  Pentwater Comes Out Swinging Against Allergan Board, Possible Salix Deal at Barrons.com
25-Sep-14 10:03PM  Pentwater Capital Management Issues Letter to Board of Directors of Allergan, Inc. CNW Group
05:39PM  Today's Market Thorns, Roses, and All Time Highs... Plus an Extra... Yahoo Finance Blogs
05:14PM  CANADA STOCKS-TSX tumbles to three-month low as sentiment sours Reuters
03:40PM  Valeant (VRX) Sends Letter to Allergan, Provides Q3 Update Zacks
03:31PM  Billionaire Bill Ackman's Concentrated Six Stock Portfolio Forbes
03:31PM  Billionaire Bill Ackman's Concentrated Six Stock Portfolio at Forbes
01:47PM  Valeant: Glaucoma Drug Is Potential Blockbuster at Investor's Business Daily
01:36PM  ValueAct returns to Valeant board, plans to raise stake Reuters
01:25PM  Valeant/Allergan: stand by me at Financial Times
01:01PM  ValueAct's Ubben To Join Valeant's Board; Valeant Shares Rise 3% at Barrons.com
11:39AM  ValueAct is Back in Valeant's Board Room, Expects to Buy More Shares at The Wall Street Journal
09:48AM  [$$] Valeant Predicts Strong Results at The Wall Street Journal
09:00AM  Allergan Issues Statement Regarding Recent Valeant Correspondence Business Wire
08:28AM  Valeant pitches potential eye drug, research focus AP
08:15AM  Valeant Names ValueActs Ubben to Board of Directors at Bloomberg
24-Sep-14 06:15PM  Cramer's favorite large cap biotech plays CNBC
05:49PM  Valeant Grows Bullish On Q3 Sales While Allergan's Defense Weakens Investor's Business Daily
05:40PM  Allergan, Inc. -- Moody's reviews Allergan's ratings for downgrade at Moody's
05:16PM  Today's Market Thorns, Roses, and All Time Highs... Yahoo Finance Blogs
03:45PM  Allergan and Salix Pharmaceuticals Up on Takeover Rumors Zacks
03:07PM  Valeant Shares Vault Higher, Boosting Allergan Bid Again at The Wall Street Journal
01:43PM  [$$] Valeant Predicts Strong Results at The Wall Street Journal
12:43PM  [$$] Ackman Threatens to Sue Allergan if It Acquires Salix at The Wall Street Journal
12:06PM  Valeant Switches to Sugar, but Allergan Still Not Biting at New York Times
11:11AM  Salix contacts Actavis over potential sale-source Reuters
10:52AM  The Latest on the Valeant-Allergan Drama in Letters at The Wall Street Journal
10:26AM  [$$] Valeant Predicts Strong Results at The Wall Street Journal
09:56AM  Valeant offers olive branch to Allergan at MarketWatch
09:05AM  Valeant Provides Update On Third Quarter Results And Sends Letter To Allergan CEO And Lead Independent Director CNW Group
09:01AM  Faber: Actavis pursues Salix CNBC
01:05AM  [$$] Ackman Threatens to Sue Allergan if It Acquires Salix at The Wall Street Journal
12:18AM  [$$] Ackman Threatens to Sue Allergan if It Acquires Salix at The Wall Street Journal
12:00AM  [$$] Ackman Threatens to Sue Allergan if It Acquires Salix at The Wall Street Journal
23-Sep-14 11:10PM  [$$] Ackman Threatens to Sue Allergan if It Acquires Salix at The Wall Street Journal
09:08PM  [$$] Ackman Threatens to Sue Allergan if It Acquires Salix at The Wall Street Journal
08:06PM  [$$] Ackman Threatens to Sue Allergan if It Acquires Salix at The Wall Street Journal
07:03PM  Cramer Remix: Stay course amid shifting winds? at CNBC
07:00PM  Two stocks you can buy now CNBC
07:00PM  [video] Two stocks you can buy now at CNBC
06:45PM  Ackman forewarns Allergan Investor's Business Daily
06:06PM  Stocks Finish Lower Among Takeover Rumors at Investor's Business Daily
05:30PM  [$$] Pershing Warns Allergan on Salix at The Wall Street Journal
05:17PM  Top Trades: BBRY & AGN CNBC
03:54PM  [$$] Pershing Warns Allergan on Salix at The Wall Street Journal
02:45PM  Tax crackdown impact on pharma deals CNBC
02:45PM  [video] Tax crackdown impact on pharma deals at CNBC
Allergan, Inc. operates as a multi-specialty health care company primarily in the United States, Europe, Latin America, and the Asia Pacific. The company discovers, develops, and commercializes pharmaceutical, biological, medical device, and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, urological, and other specialty markets. It operates in two segments, Specialty Pharmaceuticals and Medical Devices. The Specialty Pharmaceuticals segment produces a range of pharmaceutical products, including ophthalmic products for dry eye, glaucoma, inflammation, infection, allergy, and retinal disease; Botox for certain therapeutic and aesthetic indications; skin care products for acne, psoriasis, eyelash growth, and other prescription and physician-dispensed skin care products; and urologics products. The Medical Devices segment offers a range of medical devices, such as breast implants for augmentation, revision, and reconstructive surgery, as well as tissue expanders; and facial aesthetics products. The company also holds LiRIS Program, which is in Phase II trials for the treatment of interstitial cystitis/bladder pain syndrome. It sells its products to drug wholesalers, independent and chain drug stores, pharmacies, commercial optical chains, opticians, mass merchandisers, food stores, hospitals, group purchasing organizations, integrated direct hospital networks, ambulatory surgery centers, government purchasing agencies, and medical practitioners. The company focuses on eye care professionals, neurologists, physiatrists, dermatologists, plastic and reconstructive surgeons, aesthetic specialty physicians, urologists, urogynecologists, and general practitioners. It has collaboration agreements with Molecular Partners AG; Spectrum Pharmaceuticals, Inc.; and Serenity Pharmaceuticals, LLC. Allergan, Inc. was founded in 1948 and is headquartered in Irvine, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Sherman Scott DExecutive Vice President, HRApr 22Option Exercise75.5810,000755,80018,223Apr 23 07:25 PM
Sherman Scott DExecutive Vice President, HRApr 22Sale163.0010,0001,630,0008,223Apr 23 07:25 PM
Sherman Scott DExecutive Vice President, HRApr 21Option Exercise73.044,500328,68012,723Apr 23 07:25 PM
Sherman Scott DExecutive Vice President, HRApr 21Sale139.854,500629,3258,223Apr 23 07:25 PM
LAVIGNE LOUIS J JRDirectorFeb 21Sale125.795,400679,2440Feb 24 07:59 PM
INGRAM DOUGLAS SPresidentFeb 21Sale125.701961,044Feb 25 05:49 PM
Diradoorian Raymond HEVPGlobal Technical OperationsFeb 19Option Exercise58.5523,0001,346,65029,401Feb 21 04:56 PM
EDWARDS JEFFREY LEVP, Fin & Bus. Dev., CFOFeb 19Option Exercise40.1638,9001,562,22455,491Feb 21 04:59 PM
HUDSON DAWN EDirectorFeb 19Sale126.354,200530,68311,600Feb 21 05:14 PM
EDWARDS JEFFREY LEVP, Fin & Bus. Dev., CFOFeb 19Sale126.3938,9004,916,49316,591Feb 21 04:59 PM
Diradoorian Raymond HEVPGlobal Technical OperationsFeb 19Sale126.6623,0002,913,1116,401Feb 21 04:56 PM
Sherman Scott DExecutive Vice President, HRFeb 18Option Exercise75.585,000377,90013,220Feb 19 02:44 PM
Sherman Scott DExecutive Vice President, HRFeb 18Sale125.745,000628,7008,220Feb 19 02:44 PM
INGRAM DOUGLAS SPresidentFeb 14Option Exercise55.9884,0004,701,90085,058Feb 19 02:41 PM
Sherman Scott DExecutive Vice President, HRFeb 14Sale124.761708,220Feb 19 02:44 PM
INGRAM DOUGLAS SPresidentFeb 14Sale124.4084,00010,449,4321,058Feb 19 02:41 PM
PYOTT DAVID E IChairman of the Board and CEOFeb 12Option Exercise36.15252,0009,109,800417,000Feb 13 05:49 PM
BARLOW JAMES FSR. VP, Corp. Controller (PAO)Feb 12Option Exercise65.9223,8751,573,76930,754Feb 13 05:54 PM
PYOTT DAVID E IChairman of the Board and CEOFeb 12Sale123.12252,00031,025,560165,000Feb 13 05:49 PM
BARLOW JAMES FSR. VP, Corp. Controller (PAO)Feb 12Sale123.5223,8752,949,0416,879Feb 13 05:54 PM
Diradoorian Raymond HEVPGlobal Technical OperationsFeb 11Option Exercise55.9817,000951,57523,401Feb 13 05:56 PM
LAVIGNE LOUIS J JRDirectorFeb 11Option Exercise55.2054,6003,014,01924,123Feb 13 05:59 PM
Diradoorian Raymond HEVPGlobal Technical OperationsFeb 11Sale121.8217,0002,070,9576,401Feb 13 05:56 PM
LAVIGNE LOUIS J JRDirectorFeb 11Sale122.3954,6006,682,69612,723Feb 13 05:59 PM
Sherman Scott DExecutive Vice President, HRFeb 10Option Exercise75.585,000377,90013,325Feb 11 08:41 PM
Sherman Scott DExecutive Vice President, HRFeb 10Sale120.005,000600,0008,325Feb 11 08:41 PM
EDWARDS JEFFREY LEVP, Fin & Bus. Dev., CFOFeb 07Option Exercise64.47105,5006,801,585122,371Feb 11 08:37 PM
Sherman Scott DExecutive Vice President, HRFeb 07Option Exercise73.044,500328,68012,825Feb 11 08:41 PM
EDWARDS JEFFREY LEVP, Fin & Bus. Dev., CFOFeb 07Sale117.74105,50012,421,04316,871Feb 11 08:37 PM
Sherman Scott DExecutive Vice President, HRFeb 07Sale118.554,500533,4848,325Feb 11 08:41 PM
Whitcup Scott MExecutive VP, R&D, CSOJan 14Option Exercise55.9842,0002,350,95059,327Jan 15 06:24 PM
Whitcup Scott MExecutive VP, R&D, CSOJan 14Sale117.8042,0004,947,60017,327Jan 15 06:24 PM
Whitcup Scott MExecutive VP, R&D, CSOJan 08Option Exercise55.9842,0002,350,95059,327Jan 10 06:37 PM
Whitcup Scott MExecutive VP, R&D, CSOJan 08Sale113.8042,0004,779,60017,327Jan 10 06:37 PM
Gangolli Julian SCVP & Pres, North AmericaDec 27Option Exercise53.7152,5002,819,77545,547Dec 30 05:18 PM
Gangolli Julian SCVP & Pres, North AmericaDec 27Sale110.0552,5005,777,5508,047Dec 30 05:18 PM
Whitcup Scott MExecutive VP, R&D, CSODec 20Option Exercise36.1533,0001,192,95033,827Dec 20 07:41 PM
Whitcup Scott MExecutive VP, R&D, CSODec 20Option Exercise0.0033,000033,827Jan 06 06:27 PM
Whitcup Scott MExecutive VP, R&D, CSODec 20Sale108.8033,0003,590,40017,327Jan 06 06:27 PM
Whitcup Scott MExecutive VP, R&D, CSODec 20Sale108.8033,0003,590,40017,327Dec 20 07:41 PM
HUDSON DAWN EDirectorNov 27Sale97.463,000292,38215,800Dec 02 04:52 PM
Jones Trevor MDirectorOct 15Option Exercise51.721,00051,7159,142Oct 16 04:54 PM
Jones Trevor MDirectorOct 15Sale90.142,000180,2807,142Oct 16 04:54 PM